Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Clinical immunology review series: An approach to the management of pulmonary disease in primary antibody deficiency.

Literature DB >> 19128358

Clinical immunology review series: An approach to the management of pulmonary disease in primary antibody deficiency.

M D Tarzi¹, S Grigoriadou, S B Carr, L M Kuitert, H J Longhurst.

Abstract

The sinopulmonary tract is the major site of infection in patients with primary antibody deficiency syndromes, and structural lung damage arising from repeated sepsis is a major determinant of morbidity and mortality. Patients with common variable immunodeficiency may, in addition, develop inflammatory lung disease, often associated with multi-system granulomatous disease. This review discusses the presentation and management of lung disease in patients with primary antibody deficiency.

Entities: Disease Species

Mesh：

Year: 2009 PMID： 19128358 PMCID： PMC2675244 DOI： 10.1111/j.1365-2249.2008.03851.x

Source DB: PubMed Journal: Clin Exp Immunol ISSN： 0009-9104 Impact factor: 4.330

106 in total

1. Common variable immunodeficiency: clinical and immunological features of 248 patients.

Authors: C Cunningham-Rundles; C Bodian
Journal: Clin Immunol Date: 1999-07 Impact factor: 3.969

2. Early and prolonged intravenous immunoglobulin replacement therapy in childhood agammaglobulinemia: a retrospective survey of 31 patients.

Authors: P Quartier; M Debré; J De Blic; R de Sauverzac; N Sayegh; N Jabado; E Haddad; S Blanche; J L Casanova; C I Smith; F Le Deist; G de Saint Basile; A Fischer
Journal: J Pediatr Date: 1999-05 Impact factor: 4.406

3. Inhaled fluticasone in bronchiectasis: a 12 month study.

Authors: K W Tsang; K C Tan; P L Ho; G C Ooi; J C Ho; J Mak; G L Tipoe; C Ko; C Yan; W K Lam; M Chan-Yeung
Journal: Thorax Date: 2005-03 Impact factor: 9.139

4. The disease-modifying effects of twice-weekly oral azithromycin in patients with bronchiectasis.

Authors: Alicia A Cymbala; Lee C Edmonds; Michael A Bauer; Peter J Jederlinic; John J May; Jennifer M Victory; Guy W Amsden
Journal: Treat Respir Med Date: 2005

5. Heart lung transplantation in a patient with end stage lung disease due to common variable immunodeficiency.

Authors: A T Hill; R A Thompson; J Wallwork; D E Stableforth
Journal: Thorax Date: 1998-07 Impact factor: 9.139

6. Treatment of idiopathic bronchiectasis with aerosolized recombinant human DNase I. rhDNase Study Group.

Authors: A E O'Donnell; A F Barker; J S Ilowite; R B Fick
Journal: Chest Date: 1998-05 Impact factor: 9.410

7. Granulomatous interstitial pneumonitis in association with primary hypogammaglobulinemia: computed tomography appearances.

Authors: G Walsh; C D Flower; S Nasser; P W Ewan
Journal: J Thorac Imaging Date: 1999-07 Impact factor: 3.000

8. A pilot study of low-dose erythromycin in bronchiectasis.

Authors: K W Tsang; P I Ho; K N Chan; M S Ip; W K Lam; C S Ho; K Y Yuen; G C Ooi; R Amitani; E Tanaka
Journal: Eur Respir J Date: 1999-02 Impact factor: 16.671

9. The loss of IgM memory B cells correlates with clinical disease in common variable immunodeficiency.

Authors: Rita Carsetti; Maria Manuela Rosado; Simona Donnanno; Vanessa Guazzi; Annarosa Soresina; Antonella Meini; Alessandro Plebani; Fernando Aiuti; Isabella Quinti
Journal: J Allergy Clin Immunol Date: 2005-02 Impact factor: 10.793

10. Pharmacoeconomic evaluation of immunoglobulin treatment in patients with antibody deficiencies from the perspective of the German statutory health insurance.

Authors: Barbara Högy; Heinz-Otto Keinecke; Michael Borte
Journal: Eur J Health Econ Date: 2005-03

11 in total

Review 1. Bloodstream infections after solid-organ transplantation.

Authors: Antonios Kritikos; Oriol Manuel
Journal: Virulence Date: 2016-01-14 Impact factor: 5.882

2. Respiratory Complications in Patients with Hyper IgM Syndrome.

Authors: Bobak Moazzami; Reza Yazdani; Gholamreza Azizi; Fatemeh Kiaei; Mitra Tafakori; Mohammadreza Modaresi; Rohola Shirzadi; Seyed Alireza Mahdaviani; Mahsa Sohani; Hassan Abolhassani; Asghar Aghamohammadi
Journal: J Clin Immunol Date: 2019-06-11 Impact factor: 8.317

Review 3. Bringing immunoglobulin knowledge up to date: how should we treat today?

Authors: S Misbah; T Kuijpers; J van der Heijden; B Grimbacher; D Guzman; J Orange
Journal: Clin Exp Immunol Date: 2011-07-15 Impact factor: 4.330

4. Value of allohaemagglutinins in the diagnosis of a polysaccharide antibody deficiency.

Authors: H Schaballie; F Vermeulen; B Verbinnen; G Frans; E Vermeulen; M Proesmans; K De Vreese; M P Emonds; K De Boeck; L Moens; C Picard; X Bossuyt; I Meyts
Journal: Clin Exp Immunol Date: 2015-05 Impact factor: 4.330

5. Genomic Investigations unmask Mycoplasma amphoriforme, a new respiratory pathogen.

Authors: Stephen H Gillespie; Clare L Ling; Katarina Oravcova; Miguel Pinheiro; Louise Wells; Josephine M Bryant; Timothy D McHugh; Cecile Bébéar; David Webster; Simon R Harris; Helena M B Seth-Smith; Nicholas R Thomson
Journal: Clin Infect Dis Date: 2014-10-23 Impact factor: 9.079